a wholly-owned subsidiary of DRI Healthcare Trust /
Editas Medicine
DRI Healthcare Trust subsidiary to purchase Editas Medicine receivables
What happened
A wholly-owned subsidiary of DRI Healthcare Trust agreed to purchase certain future license fees and other payments owed to Editas Medicine, Inc. The agreement provides for an upfront cash payment of $57.0 million.
Editas Medicine retains some rights to payments under its Cas9 license agreement with Vertex Pharmaceuticals.
The source
Everything on this page comes from the source below.
DRI Healthcare Trust subsidiary to purchase Editas Medicine receivables
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly